Published in JAMA on August 11, 1993
Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol (1990) 8.97
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia (2009) 4.53
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids (2003) 3.66
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia (2009) 3.49
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia (2009) 3.23
Turnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysis. Proc Natl Acad Sci U S A (1981) 2.93
Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A (1997) 2.76
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia (2010) 2.65
Critical care in the emergency department: a time-based study. Crit Care Med (1993) 2.59
Protein oxidation. Ann N Y Acad Sci (2000) 2.57
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations. Leukemia (2007) 2.49
Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. J Biol Chem (1983) 2.29
Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci U S A (2001) 2.04
Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med (1994) 2.03
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms. Leukemia (2011) 1.88
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production. Oncogene (2011) 1.87
Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem (2000) 1.82
Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci U S A (2000) 1.82
Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem (1989) 1.80
DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia (2011) 1.79
Oxidative modification of glutamine synthetase. II. Characterization of the ascorbate model system. J Biol Chem (1983) 1.78
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia (2008) 1.78
Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry (2000) 1.70
Purification of a protease from Escherichia coli with specificity for oxidized glutamine synthetase. J Biol Chem (1987) 1.68
Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A (1998) 1.66
Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia (2009) 1.63
Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem (1999) 1.63
Cardiac arrest presenting with rhythms other than ventricular fibrillation: contribution of resuscitative efforts toward total survivorship. Crit Care Med (1993) 1.61
Metal-catalyzed oxidation of Escherichia coli glutamine synthetase: correlation of structural and functional changes. Arch Biochem Biophys (1990) 1.57
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
Evidence for transhemispheric diaschisis in unilateral stroke. Arch Neurol (1989) 1.54
Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. J Biol Chem (1994) 1.53
Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol (1989) 1.49
Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J Exp Med (1999) 1.45
Dose-dependent vasopressor response to epinephrine during CPR in human beings. Ann Emerg Med (1989) 1.44
Use of laparoscopically mobilized peritoneum in the creation of a neovagina. Fertil Steril (2000) 1.39
Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem (2001) 1.30
Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation. Proc Natl Acad Sci U S A (1999) 1.28
Sequence of a peptide susceptible to mixed-function oxidation. Probable cation binding site in glutamine synthetase. J Biol Chem (1986) 1.27
The AAGL classification system for laparoscopic hysterectomy. Classification committee of the American Association of Gynecologic Laparoscopists. J Am Assoc Gynecol Laparosc (2000) 1.24
Quantitation of aromatic residues in proteins: model compounds for second-derivative spectroscopy. Biochemistry (1982) 1.24
Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms. Proc Natl Acad Sci U S A (1991) 1.24
Selectivity of protein oxidative damage during aging in Drosophila melanogaster. Biochem J (2001) 1.24
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch Biochem Biophys (1996) 1.22
Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med (1995) 1.21
NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases. Leukemia (2010) 1.20
Conversion of carbamoyl phosphate to hydroxyurea. An assay for carbamoylphosphate synthetase. Anal Biochem (1971) 1.19
Emergency department procedures and length of stay for critically ill medical patients. Ann Emerg Med (1994) 1.18
The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration. Leukemia (2010) 1.18
Regulation of HIV-1 protease activity through cysteine modification. Biochemistry (1996) 1.18
Inactivation of glycerol dehydrogenase of Klebsiella pneumoniae and the role of divalent cations. J Bacteriol (1985) 1.17
Recent advances in the analysis of oxidized proteins. Amino Acids (2003) 1.17
Swallowing after unilateral stroke of the cerebral cortex. Arch Phys Med Rehabil (1993) 1.17
Covalent modification of proteins by mixed-function oxidation: recognition by intracellular proteases. Prog Clin Biol Res (1985) 1.16
Comparison of the effects of ozone on the modification of amino acid residues in glutamine synthetase and bovine serum albumin. J Biol Chem (1996) 1.16
Pharmacology of furosemide in the premature newborn infant. J Pediatr (1980) 1.16
The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. Proc Natl Acad Sci U S A (1996) 1.15
Systematic genomic screen for tyrosine kinase mutations in CLL. Leukemia (2008) 1.14
End-tidal CO2: physiology in pursuit of clinical applications. Intensive Care Med (2000) 1.14
The effect of applied chest compression force on systemic arterial pressure and end-tidal carbon dioxide concentration during CPR in human beings. Ann Emerg Med (1989) 1.10
Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod Pathol (2000) 1.08
Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J Biol Chem (1995) 1.08
Crystalloids vs colloids ... again? Acad Emerg Med (1995) 1.08
Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc Natl Acad Sci U S A (2001) 1.07
A role of mixed-function oxidation reactions in the accumulation of altered enzyme forms during aging. J Am Geriatr Soc (1987) 1.06
Copurification of carbamoyl phosphate synthetase and aspartate transcarbamoylase from mouse spleen. Biochem Biophys Res Commun (1971) 1.05
HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. Biochem J (2000) 1.04
Use of end-tidal carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med (1995) 1.04
Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci U S A (1998) 1.03
Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal Biochem (1989) 1.02
Fluorescence-quenching studies of the binding of bilirubin to albumin. Clin Chem (1977) 1.02
Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites. J Urol (1979) 1.02
AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia (2013) 1.01
Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms. Leukemia (2008) 1.00
Forward and reverse selection for longevity in Drosophila is characterized by alteration of antioxidant gene expression and oxidative damage patterns. Exp Gerontol (2000) 1.00
Mixed-function oxidation of histidine residues. Methods Enzymol (1984) 0.99
Entry of bilirubin into the brain due to opening of the blood-brain barrier. Pediatrics (1982) 0.98
Reactivity of cysteine residues in the protease from human immunodeficiency virus: identification of a surface-exposed region which affects enzyme function. Arch Biochem Biophys (1993) 0.98
Oxidation of proteins in neonatal lungs. Pediatrics (1994) 0.98
MDP-1: A novel eukaryotic magnesium-dependent phosphatase. Biochemistry (2000) 0.95
Aging of the liver: proteolysis of oxidatively modified glutamine synthetase. Arch Biochem Biophys (1995) 0.95
Effects of thermal application on dysphagia after stroke. J Speech Hear Res (1991) 0.95
Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. Arch Neurol (1988) 0.94
Modulation of the hydrophobicity of glutamine synthetase by mixed-function oxidation. FASEB J (1988) 0.94
A review: biological and clinical aspects of pyrimidine metabolism. Pediatr Res (1974) 0.93
Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation (1997) 0.92
Effect of carotid artery stenting on cognitive function in patients with carotid artery stenosis: preliminary results. AJNR Am J Neuroradiol (2007) 0.92
Derivatization of gamma-glutamyl semialdehyde residues in oxidized proteins by fluoresceinamine. Anal Biochem (1989) 0.92
Plasticity in the adult frog brain: filling the visual scotoma after excision or translocation of parts of the optic tectum. Brain Res (1975) 0.91
Carbon disulfide-induced neuropsychiatric changes in grain storage workers. Am J Ind Med (1982) 0.91
Oxidation of the active site of glutamine synthetase: conversion of arginine-344 to gamma-glutamyl semialdehyde. Arch Biochem Biophys (1991) 0.90
Stability of implanted duplicate tectal positional markers serving as targets for optic axons in adult frogs. Brain Res (1975) 0.89
Influence of age upon complications of carotid artery stenting. UAB Neurovascular Angioplasty Team. J Endovasc Surg (1999) 0.88
Modification of proteins in endothelial cell death during oxidative stress. Free Radic Biol Med (1997) 0.88
Carbonic anhydrase III: the phosphatase activity is extrinsic. Arch Biochem Biophys (2000) 0.87
Urethral cancer. Cancer (1980) 0.87
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. Leukemia (2011) 0.86
Individual differences in phenomenological experience: states of consciousness as a function of absorption. J Pers Soc Psychol (1985) 0.86